Virtual Visits by Supportive Care Specialists to Cancer Patients at Home: A Randomized Controlled Pilot Noninferiority Trial of Video Telemedicine
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Enrollment
- 33
- Locations
- 1
- Primary Endpoint
- Health-Related Quality of Life: FACT-G
- Status
- Completed
- Last Updated
- 9 months ago
Overview
Brief Summary
This study will test whether supportive care follow-up delivered to cancer patients at home by telemedicine ("virtual" medical visits using telecommunications technologies) is as effective as in-person supportive care visits in the clinic.
Detailed Description
The protocol was developed and initially implemented when the standard of care for Supportive Care (and oncology) follow-up at MSK was in-person visiting and home telemedicine was only in an early stage of use at the institution. During the COVID-19 crisis, all outpatient Supportive Care visits and most oncology visits at MSK have been handled via telemedicine to protect patient (and staff) safety.
Investigators
Eligibility Criteria
Inclusion Criteria
- •age 18 years or older
- •solid tumor of any type
- •completed an initial in-person clinic visit (i.e. an IR/NV or AFX visit) at Rockefeller Outpatient Pavilion with Dr. Saldivar, Dr. Martin, Supportive Care physicians, or Andrea Dolan, a Supportive Care nurse practitioner
- •planned for Supportive Care Service follow-up visits, but none yet completed
- •enrolled on the MyMSK secure online patient portal and have access to the portal off site of MSK campuses
- •resident of New York or New Jersey or Connecticut (clinicians may not be licensed in other states, as would be required for televisits to patients there)
Exclusion Criteria
- •Patients and informal caregivers who cannot communicate with clinicians/respond to instruments in English without the use of an interpreter
Outcomes
Primary Outcomes
Health-Related Quality of Life: FACT-G
Time Frame: Week 14
will be used to quantify health-related quality of life at baseline and Week 14 after randomization. All items in the FACT-G use a 5-point scale (0=Not at all to 4=Very much) and the total score sums four subscales and ranges from 0-108 (higher=better QoL). Change in total score at Week 14 after randomization vs. baseline.